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The aim of the work was to evaluate whether or not there is glycolytic reprogramming in the neighboring
cells of colorectal cancer (CRC). Using postoperative material we have compared the functional capacity
of oxidative phosphorylation (OXPHOS) in CRC cells, their glycolytic activity and their inclination to
aerobic glycolysis, with those of the surrounding and healthy colon tissue cells. Experiments showed that
human CRC cannot be considered a hypoxic tumor, since the malignancy itself and cells surrounding it
exhibited even higher rates of OXPHOS than healthy large intestine. The absence of acute hypoxia in
colorectal carcinomas was also conﬁrmed by their practically equal glucose-phosphorylating capacity as
compared with surrounding non-tumorous tissue and by upregulation of VEGF family and their ligands.
Studies indicated that human CRC cells in vivo exert a strong distant effect on the energy metabolism of
neighboring cells, so that they acquire the bioenergetic parameters speciﬁc to the tumor itself. The
growth of colorectal carcinomas was associated with potent downregulation of the creatine kinase
system. As compared with healthy colon tissue, the tumor surrounding cells display upregulation of
OXPHOS and have high values of basal and ADP activated respiration rates. Strong differences between
the normal and CRC cells in the afﬁnity of their mitochondria for ADP were revealed; the corresponding
Km values were measured as 93.677.7 mM for CRC cells and 84.979.9 mM for nearby tissue; both these
apparent Km (ADP) values were considerably (by almost 3 times) lower in comparison with healthy colon
tissue cells (256734 mM).
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).B.V. This is an open access article u
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e).1. Introduction
Colorectal cancer (CRC) is a major cause of cancer death
worldwide necessitating new strategies for treatment of this dis-
ease. Recent studies show that targeting cancer cell energy me-
tabolism is possibly a new and very effective therapeutic approach
for selective ablation of malignancies [39,61,70]. Intracellular ATP
levels may be a key determinant of chemoresistance of human CRC
cells [110]. There are some indications in literature that mi-
tochondria (the main cell system for ATP generation) could play a
supportive or possibly even a triggering role in metastasis of
cancer cells [4].nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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in bioenergetics and mitochondrial research. During that time, Otto
Heinrich Warburg observed abnormally high glycolysis and lactate
production in cancer cells even in the presence of oxygen (later
named as “aerobic glycolysis“), leading him to suggest that defects in
mitochondrial functions are at the heart of malignant cell transfor-
mation [117].
The exact mechanisms mediating the strong tendency of some
cancers to aerobic glycolysis remain still unclear. Several different
hypothesis have been proposed to explain the causes of the War-
burg effect, such as: 1) poor tumor vascularization leading to hy-
poxia-induced dysfunction of mitochondria [95] and stabilization
of HIF-1α-a master of regulation of glycolytic ﬂuxes [103], 2) post-
translational modiﬁcations, 3) glutamine metabolism [26,29]; 4)
miRNA expression [42], 5) epigenetic changes [17], 6) nuclear and
mitochondrial DNA mutations [10,18] leading to mitochondrial
dysfunction in cancer cells [77], and 7) oncogene activation and
loss of tumor suppressor genes function [115].
A very attractive hypothesis for explanation of the Warburg
phenomenon was proposed by Pedersen and colleagues [75]. They
have suggested that in highly glycolytic malignant cells the over-
expression of hexokinase-2 (HK-2) associated with its binding to
voltage-dependent anion channel (VDAC, located on the outer
mitochondrial membrane) plays a crucial role in mediating their
high rate of aerobic glycolysis. In tumor cells, the interaction of
HK-2 with VDAC induces very rapid phosphorylation of glucose
through the use of mitochondrially-generated ATP. Also, the
binding of HK-2 to mitochondria strongly (almost 5-fold) increases
its afﬁnity for ATP [12]. It is important to note that binding of HK-2
to VDAC maintains this channel in the open state [98] which fur-
ther facilities the transport of adenine nucleotides across mi-
tochondrial membranes in malignant cells. In cancer tissues, the
high glycolytic activity requires an up-regulation of the key gly-
colytic enzymes including HK(s). Interestingly, the percentage of
hexokinase binding to the mitochondria is also signiﬁcantly in-
creased in some cancer cells. For instance, in AS-20D liver tumor
cells, the hexokinase protein level (mainly HK-2) was found to be
more than 500 times higher than in normal liver cells, which
mainly express HK-IV instead. Furthermore, around 80% of HK-2 is
found to be associated with mitochondria [7]. Due to the frequent
up-regulation of HK-2 in cancer cells and its important role in
glycolytic pathway, this enzyme seems to be an attractive target
for anticancer drug development. In line with this, Chen et al. [19]
have shown treatment of cancer cells with 3-bromopyruvate (an
inhibitor of glycolysis) caused a covalent modiﬁcation of HK-2
protein that triggered its dissociation from mitochondria, leading
to a speciﬁc release of apoptosis-inducing factor from the mi-
tochondria to cytosol and cell death.
The regulation of mitochondrial function is a central issue in
the bioenergetics of cancer cell. Studies performed during the past
decade showed that interaction between cytoskeletal proteins and
mitochondria is deeply involved in the regulation of mitochondrial
function. A lot of experimental data demonstrate the importance
of the structural factors in the intracellular arrangement of mi-
tochondria and in the control of outer mitochondrial membrane
permeability [104,118,40,45,47,5,6]. Potential candidates for the
key roles in this regulation are the cytoskeletal proteins such as
plectin and tubulin [118,45,47,5,6,63]. It was hypothesized that in
high-energy demand tissues there is a colocalization of β-tubulin
isotype II with mitochondria (through VDAC) and it was suggested
that it can be coupled with the adenine nucleotide translocase
(ANT), mitochondrial creatine kinase (MtCK) and VDAC. This mi-
tochondrial supercomplex (ANT-MtCK-VDAC) is responsible for
the efﬁcient intracellular energy transfer via the phosphocreatine
(PCr) pathway. It is shown that the localization and function of β-
tubulin isotypes varied in different muscle tissues and neoplasticcells [112,118,63,78].
Recent investigations have clariﬁed the beneﬁts and selective
advantages of aerobic glycolysis. Although glycolysis yields a lower
amount of ATP compared to mitochondrial OXPHOS, several key
beneﬁts inherent in aerobic glycolysis drive cancer cells to favor
glycolysis over mitochondrial oxidation [28]. Firstly, it was pro-
posed [91] that the high rates, but low yields of ATP production
through glycolysis, may give selective advantage under rivalry for
shared energy sources. Moreover, the rate of ATP generation may
be 100 times faster with glycolysis as compared with OXPHOS
[36]. The low efﬁciency of ATP generation by glycolysis is never-
theless sufﬁcient to meet intracellular demand. Secondly, besides
ATP, cancer cells need additional metabolic intermediates and
precursors that are decisive for the biosynthesis of macro-
molecules, the ultimate building blocks necessary to expand the
tumor mass during its growth and proliferation [116]. Currently,
human CRC is considered as a neoplasm of the Warburg pheno-
type with deregulated OXPHOS system. Positron emission tomo-
graphy (PET) with 18-ﬂuorodeoxyglucose (FDG) showed that the
malignancy exhibits, as compared to surrounding normal intestine
tissue, higher rates of glucose consumption [22] that in turn was
associated with increased intratumoral levels of lactic acid [54],
overexpression of GLUT-1 [48] and genes encoding glycolytic en-
zymes such as pyruvate kinase M2 (PKM2) [1], glyceraldehyde-3-
phosphate dehydrogenase and enolase-1α [3], LDH5 [62], and HK-
2 [52].
It is becoming evident that the upregulation of glycolysis ex-
hibited by some cancer cells does not necessarily imply a strict
anaerobic phenotype or a dysfunctional OXPHOS system. Rather, it
is believed that the normal interplay between the glycolysis in the
cytosol and OXPHOS in the mitochondria becomes disturbed or
reprogrammed in tumor cells; the Crabtree effect was observed in
cancer cells that exempliﬁes the intimate connection between
glycolysis and the oxidative metabolism [90]. Moreover, recent
studies have shown that not all tumor mitochondria display OX-
PHOS deﬁciency [111,121,30,60,95]. The OXPHOS system may be
the principal ATP producer (490%) for several malignant tumor
cell types under normoxic conditions [111,96,97]. Therefore, drug
therapy targeting OXPHOS has emerged as an important alter-
native for growth arrest of oxidative type tumors [39,82,96].
In our recent study, we clearly showed that CRC cannot be re-
garded as a tumor of purely Warburg phenotype and that in these
cancer cells the OXPHOS system is the main energy source instead
of aerobic glycolysis [58]. Although total glycolytic capacity of
human CRC cells was found to be similar with normal cells, all
their respiratory rates (both basal and ADP-activated) exceeded
considerably those of healthy colon tissue samples. Furthermore,
our studies indicated that the OXPHOS system may be even up-
regulated in CRC cells; the content of mitochondria in human CRC
cells was found to be at least 2-times higher than that in healthy
colon tissue cells [58].
Recently, a new framework of “Reprogramming the of Tumor
Stroma metabolism” or “Reverse Warburg effect” was introduced
in experimental oncology [108,123,68]. According to the paradigm,
there is metabolic coupling between mitochondria in cancer cells
and catabolism in stromal cells that promotes tumor growth and
metastasis. In another words, cancer cells can induce the repro-
gramming of tumor microenvironment (ﬁbroblasts, macrophages
and other tumor-associated cells) towards the Warburg pheno-
type, so they donate the necessary fuels (L-lactate, ketone bodies,
glutamine and others) to anabolic cancer cells, which metabolize
these via the tricarboxylic acid cycle (TCA) and OXPHOS. Pioneer-
ing studies showed that such metabolic symbiosis may occur be-
tween breast cancer cells and the tumor stromal ﬁbroblasts
[107,120,73], and now this paradigm has extended to other ma-
lignancies like osteosarcoma, ovarian cancer, head and neck
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in the case of human CRC the concept of “reverse Warburg” effect
was not explored yet.
Though the above described form of “parasitic metabolism” in
malignancies has only recently been proposed, transfer of energy
precursors between cells to fuel growth is actually not a new
discovery, but instead reﬂects the co-optation of normal physio-
logical processes by tumor cells.
Taking into account the information presented above, the aim
of the work was to estimate whether or not there is metabolic
reprogramming in the human CRC surrounding cells. For this
purpose, we used postoperative material, to estimate the glycolytic
capacity of human CRC cells, their inclination towards aerobic
glycolysis (coupling between HK processes and the OXPHOS sys-
tem) and compared these parameters with those of healthy colon
tissue and the tumor surrounding cells (nearby tissue). In addition,
in situ experiments with the use of “permeabilized cell” techniques
were carried out to compare the bioenergetic function of mi-
tochondria in these tissues as well as the role of adenylate and
creatine kinase systems in maintaining energy homeostasis.2. Materials and methods
2.1. Reagents
Unless otherwise indicated, all chemicals were purchased from
Sigma-Aldrich Chemical Com. (USA). Primary and secondary an-
tibodies were obtained from Santa Cruz Biotechnology Inc. or
Abcam PLC, rabbit polyclonal antibodies vs. VDAC were kindly
donated by Dr. Catherine Brenner from Paris-Sud University,
France.
2.2. Clinical materials and patients
CRC and normal tissue samples (0.1–0.5 g) were provided by
the Oncology and Hematologic Clinic at the North Estonia Medical
Centre, Tallinn. Pathology and histological reports were provided
by the oncology clinic for each tissue sample. All patients ex-
amined (n¼55, with ages ranging from 63 to 92 years) had local or
locally advanced disease (T2-4, N0-1, M0-1). Only primary samples
of adenocarcinoma were examined. The patients in the study had
not received prior radiation or chemotherapy. All investigations
were approved by the Medical Research Ethics Committee (Na-
tional Institute for Health Development, Tallinn) in accordance
with Helsinki Declaration and Convention of the Council of Europe
on Human Rights and Biomedicine. Normal colon tissue samples
were taken at sites distant from the tumor by 5 cm and they were
controlled for presence of cancer cells. Nearby tissue is the junc-
tion area between cancer and normal mucosa. In addition, we
performed molecular characterization of tissue samples from 35
patients (both tumor and normal) using microsatellite instability,
CpG island methylator phenotype (CIMP) and 5-hydroxymethyla-
tion assay. CIMP is one of the mechanisms involved in colorectal
carcinogenesis [38]. Our studies showed that both non-tumorous
tissue samples (nearby and healthy) had a stable microsatellite
proﬁle and no CIMP phenotype. Also, the 5-hydroxymethylation
expression was statistically signiﬁcantly higher in both control and
neighboring tissue samples as compared to tumor that was ana-
lyzed in 13 patients (Supplementary Fig. 1). 5-hydroxymethylation
analysis was carried out according to manufacturer instructions
provided with the MethylFlash Hydroxymethylated DNA Quanti-
ﬁcation Kit (Epigentek, USA).
2.3. Preparation of tumor ﬁbers, permeabilization procedure, andassessment of mitochondrial respiration in situ
Numerous studies have demonstrated that isolated mitochon-
dria behave differently from mitochondria in situ with respect to
respiratory activity [101]. Therefore, we investigated mitochon-
drial respiratory activity of tumor and non-tumorous tissues in situ
using the skinned ﬁber technique [101,56,58,65], which allows
analyzing the function of mitochondria in a cell in their natural
surroundings. This technique leaves the links of these organelles
with cytoskeletal structures intact. Immediately after surgery, the
tissue samples treated as described previously [56] and the re-
spiration of State 2 and ADP activated respiration was measured.
2.4. Mitochondrial respiration in saponin-permeabilized tissue
samples
Rates of O2 consumption by skinned tissue ﬁbers were assayed
at 25 °C by an Oxygraph-2k high resolution respirometer (Or-
oboros Instruments, Innsbruck Austria) in pre-equilibrated re-
spiration buffer (medium-B supplemented with 5 mM glutamate
and 2 mM malate or 10 mM succinate as respiratory substrates) as
described previously [65]. The solubility of oxygen at 25 °C was
taken as 240 nmol/ml [37]. All respiration rates were normalized
per mg dry weight of tissue.
2.4.1. Analysis of OXPHOS coupling with hexokinase, adenylate and
creatine kinase mediated processes
The coupling of mitochondrially-bound hexokinases with the
OXPHOS system in permeabilized tumor and non-tumorous tis-
sues was assayed by oxygraphy through stimulation of mi-
tochondrial respiration by locally-generated ADP [58]. The glucose
effect on mitochondrial respiration was expressed by glucose in-
dex (IGLU) that was calculated according to the equation: IGLU
(%)¼[(VGLUVATP)/(VADPVATP)]*100, where VADP is the rate of O2
consumption in the presence of 2 mM, VGLU-respiration rates with
10 mM glucose, and VATP is respiration rate with 0.1 mM ATP; i.e.
this index reﬂects the degree glucose-mediated stimulation of
mitochondrial respiration as compared to maximal ADP-activated
rates of O2 consumption.
The adenylate kinase (AK) coupling with OXPHOS was esti-
mated by respirometry using modiﬁed protocols of [43]. Then AK
index (IAK) was calculated according to the equation:
IAK¼(VAMPVAP5A)/VAP5A, where VAMP and VAP5A are mitochondrial
respiration rates in the presence of 2 mM AMP and 0.2 mM dia-
denosine pentaphosphate (AP5A, an inhibitor of AK), respectively.
This index shows the efﬁciency of the functional coupling between
AK and mitochondrial OXPHOS.
The functional coupling between mitochondrial creatine kinase
(CK) and OXPHOS system was estimated by respirometry essen-
tially as described previously [114,56].
2.5. Determination of enzymatic activities
HK activity was measured as the total glucose phosphorylating
capacity of whole tissue extracts, using a standard glucose-6-
phosphate dehydrogenase coupled spectrophotometric assay [94].
The CK activity was assessed spectrophotometrically at 25 °C in
the direction of ATP formation [78]. One mU of CK activity re-
presents the formation of 1 nmole of ATP per minute at 25 °C.
AK activity of whole-tissue extracts was measured at 25 °C by a
coupled enzyme assay [33]. All enzymatic activities were nor-
malized per mg of tissue protein. The protein content of tissue
extracts was determined by a Pierce BCA Protein Assay Kit ac-
cording to the manufacturer recommendations using BSA as a
standard.
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VDAC expression in postoperative tissue samples
Postoperative tissues were frozen in liquid N2 and crushed to a
powder. The powder was then suspended in 20 volumes of mi-
crotubule lysing buffer containing 100 mM PIPES, 5 mM MgCl2,
1 mM EGTA, 30% glycerol, 0.1% IGEPAL, 0.1% Tween-20, 0.1% Triton
X-100, 0.1% beta-mercaptoethanol, 1 mM ATP, 0.1 mM GTP and
complete protease inhibitor cocktail (Roche); the recipe is ac-
cording to Cytoskeleton Inc. The lysate was homogenized by
Retsch Mixer Mill at 25 Hz for 2 min, and incubated for 30 min at
35 °C. The obtained tissue lysates were then clariﬁed by cen-
trifugation at 21,000 g for 40 min at 35 °C. The protein con-
centration in lysates was determined using the Pierce BCA Protein
Kit. Proteins were separated by 12% SDS-PAGE and transferred
onto PVDF membrane by Trans-Blot Semi-Dry Transfer system
(Bio-Rad).
For determinations of the presence of beta-tubulin isotypes
Abcam mono- and polyclonal antibodies (Anti beta I Tub
(ab11312), Anti Tubb2A (ab170931), Anti beta III Tub (ab52901),
Anti beta IV (ab11315)) were used. For VDAC detection, rabbit
polyclonal antibody, kindly provided by Dr Catherine Brenner
(Paris-Sud University, France) was used. Secondary antibodies
were accordingly: anti-mouse (ab97046) and anti-rabbit (ab6721)
HRP conjugates. After chemoluminescence reaction, the PVDF
membranes were stained with Coomassie brilliant blue R250 to
measure the total protein amount. The beta tubulin isoforms and
VDAC signal intensities were calculated by ImageJ software and
normalized to total protein intensities; staining with Coomassie is
routinely used as loading control in Western blot analysis. Besides,
after enzymatic chemiluminescence reaction and imaging, the
PVDF membrane was washed once with Tris-buffered saline, re-
colored with Coomassie brilliant blue for 5 min, distained and
dried completely, and then was imaged again [119].
2.7. RNA isolation and real-time quantitative RT-PCR (qRT-PCR)
The technique of qRT-PCR was applied to estimate the expression
of genes encoding main members of the vascular endothelial growth
factor family (VEGFs) and their receptors (such as VEGF-A, -B, -C, FLT-1,
FLT-4 KDR, NRP-1 and NRP-2) in human CRC, neighboring non-tu-
morous and healthy colon tissues. Total RNA from frozen postoperative
tissue samples (n¼47) was isolated by means of Trizol (Life Technol-
ogies) solution, followed by puriﬁcation using the RNeasy Mini Kit
(QIAGEN Sciences) with DNase treatment. Extracted RNA was dis-
solved in RNase-free water, quality and concentration were measured
using Nanodrop and RNA was stored at 80 °C until cDNA synthesis.
For cDNA synthesis 2 mg of total RNAwas used. cDNAwas synthesized
using High Capacity cDNA Reverse Transcription Kit with RNase In-
hibitor (Applied Biosystems). cDNA was used as a template for
TaqMan
s
quantitative RT-PCR (qRT-PCR) analysis in the Roche Light-
Cycler 480 system (Roche). TaqMans Gene ExpressionMaster Mix and
FAM labeled TaqMan
s
(Applied Biosystems) gene assays were used to
detect the mRNA expression level of the gene of interest and of actin
as a reference gene. The following primers were used to determine the
relative gene expression using qPCR: vegf-a (Hs00900055_m1), vegf-b
(Hs00173634_m1),vegf-c (Hs00153458_m1), ﬂt-1(Hs01052961_m1),
ﬂt-4 (Hs01047677_m1), kdr (Hs00911700_m1), nrp-1(Hs0082612
8_m1), nrp-2 (Hs00187290_m1). Reactions were carried out in four
replicates. Data were analyzed by the 2(Delta Delta C(T)) method
[71], where the gene expression levels were normalized to the level of
actin beta housekeeping gene. The data of studied genes following
normal distribution were parametrically tested by unpaired Student
t-test.
qRT-PCR analysis of the level of mRNA expression for CK(s), HK-
1 and HK-2 was carried out as described in our previous work [58].2.8. Statistical analysis
All results are presented as a mean value7standard error
(SEM). They were analyzed by Student's t-test, and p-valueso0.05
were considered statistically signiﬁcant. Apparent Km values for
ADP were measured by ﬁtting experimental data to a non-linear
regression or double reciprocal Lineweaver–Burk plot according to
a Michaelis–Menten equation. In our studies, cutoff values were
calculated by using of available SigmaPlot 11 software, Systat
Software, Inc.3. Results
3.1. Evaluation of the function of OXPHOS system in human CRC and
surrounding non-tumorous tissues
Our study was based on the hypothesis that epithelial CRC cells
induce the Warburg effect (aerobic glycolysis) in neighboring tis-
sue cells. In this situation, suppression of the mitochondrial
function in association with the upregulation of glucose con-
sumption could occur in nearby tissue cells. Perhaps, the increased
glucose uptake registered by PET-FDG in CRC patients [22] is lar-
gely mediated by the higher glycolytic capacity of the tumor
stroma as compared to its parenchymal cells. In addition, our prior
studies on the function of OXPHOS system in CRC and healthy
colon tissue cells are in line with the concept of reverse Warburg
effect. In the current study we found that human CRC cells have
fully-active respiratory chain (Fig. 1). CRC cells display higher rates
of State 2 and State 3 oxygen consumption as compared with
healthy colon tissue [58]; the measured rates of maximal ADP
stimulated respiration (Vm) for tumor and normal tissues corre-
lated well with their mitochondrial content [58]. Besides, it was
found that both CRC and healthy colon tissues exhibit practically
equal total glucose-phosphorylating activity (Table 1) [58]. These
ﬁndings led us to the conclusion that human CRC is not a glycolytic
tumor and in these cancer cells the OXPHOS system may be the
Table 1
Enzymatic activities in human colorectal cancer and surrounding non-tumorous
tissue samples.
Enzyme activities, mU
(s) per mg protein
Tissues, mean7SE
Healthy colon
tissue
Nearby Colorectal
cancer
Hexokinase 244750 172730,
p¼0.12
215740,
p¼0.33
Creatine kinase 4977142 202752,
po0.05
204784,
po0.05
Adenylate kinase 257735 256735,
p¼0.49
411743,
po0.05
Notes:p-values were calculated by Student test vs. control non-tumorous tissue
data; number of examined samples was 11 – 16.
Table 2
The values of basal respiration rate (V0), maximal rate of respiration (Vm, was cal-
culated from a titration curve after step-wise addition of ADP, up to 2 mM), ap-
parent Km values for ADP for permeabilized human colorectal cancer and sur-
rounding tissue samples as well as some healthy rat muscle tissues of different
histological type.
Tissue V0 KmappADP, lM Vm Source
Colorectal cancera 1.9970.26 93.677.7b 3.8270.32* Our data
Nearby tissuec 1.6470.27 84.979.9b 2.9870.34* Our data
Healthy colon
tissuec
1.1370.12 256734b 1.9270.14 Our data
Rat heart ﬁbers 6.4570.19 297735 28.771.1 [56,64]
Rat soleus 2.1970.30 354746 12.270.5 [56,64]
Rat gastro-
cnemius white
1.2370.13 14.472.6 7.070.5; 4.1070.25 [56,64]
* signiﬁcant difference vs. normal intestinal tissue, po0.05.
a All respiratory rates are given as nmol O2/min/mg dry weight of tissue.
b These apparent Km values were determined by ﬁtting experimental data to a
non-linear regression equation (according to a Michaelis–Menten model).
c Nearby and healthy intestinal tissue samples were taken at a site distant from
the tumor locus by 2 and 5 cm, respectively.
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stromal cells support the CRC cells growth by fueling their OX-
PHOS. But, the functional capacity of mitochondria in neighboring,
to the malignancy growth area tissue was remained to be ex-
plored. Hereby, we have performed the corresponding compara-
tive studies, and this is very important especially in the light of the
concept of “reverse Warburg” effect.
For this purpose, we analyzed the function of the mitochondrial
electron transport chain (ETC) components in non-neoplastic, CRC,
and nearby tissues using saponin-skinned samples. It was found
(Fig. 1) that nearby tissue has relatively high rates of State 2 and
ADP-activated respiration; in the presence 2 mMmalate and 5 mM
glutamate as respiratory substrates, the mean value V0 (State 2)
was assayed as 1.5970.37 nmol O2/min/mg dry tissue weight and
it was increased after addition of 2 mM ADP by almost 2 times
(2.9770.53 nmol O2/min/mg dry tissue weight, po0.05), con-
ﬁrming the presence of functionally-active mitochondria. The va-
lues of V0 and the respiration rate in the presence of 2 mM ADP for
neighboring tissue exceeded notably (by 1.5 times) the values
obtained for skinned healthy colon tissue ﬁbers. The ADP-activated
respiration was strongly inhibited in all tissue samples upon ad-
dition of rotenone; this is a characteristic feature of cells with
active Complex-I (Fig. 1). The differences of respiration rates be-
tween these three types of tissues are not statistically signiﬁcant
and it can be concluded that the development of colorectal cancer
was not accompanied with suppression of complex I-dependent
respiration as described in gastric cancer [92]. The next step was to
estimate the Complex-II dependent respiration that can be
achieved by addition of its substrate – succinate. We found that
the addition of succinate (10 mM) leads to increase in the rates of
O2 consumption suggesting that Complex-II of the mitochondrial
respiratory chain is functionally active in these tissues cells. The
ADP stimulated respiration was suppressed by addition of 10 μM
antimycin-A (inhibitor for Complex-III); this result shows that the
mitochondrial respiratory chain Complex III is also functionally
active not only in unaffected tissue, but also in CRC cells. To acti-
vate cytochrome-c oxidase (COX) 1 mM N,N,N′,N′-tetramethyl-p-
phenylenediamine (TMPD) jointly with 5 mM ascorbate were ad-
ded and this resulted in a very strong increase in the rate of O2
consumption by all examined tissue samples (Fig. 1). The cyto-
chrome c test is used to investigate the quality of the outer mi-
tochondrial membrane after treatment of the tissue. Permeabili-
zation of ﬁbers does not alter the permeability of the outer mi-
tochondrial membrane since addition of exogenous cytochrome c
has no effect on respiration of the ﬁbers [101]. The intactness of
inner mitochondrial membrane was controlled by carboxya-
tractyloside (CAT). Upon addition of the inhibitor, the respiration
rate decreased back to the basal respiration level due to inactiva-
tion of ANT [114].
Respiratory control index (RCI) values for tumor and non-tumorous tissues were the following: 2.0 for CRC,1.8 for the
neighboring tissue and1.7 for unaffected colon tissue. The
maximal rates of ADP-activated respiration (Vm) for cancerous and
nearby tissue were found to exceed considerably those of healthy
colon tissue (Table 2). This could be largely driven by the differ-
ence in the cellular content of mitochondria. In this connection, we
estimated the content of mitochondria in tumorous and non-tu-
morous tissues through the analysis of VDAC protein expression.
Western-blot analysis showed (Fig. 2) that CRC and neighboring
tissue cells exhibited manifold higher levels of VDAC expression
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healthy colon tissue, that in turn correlated directly with the
measured Vm values (Table 2). In general, our estimations of the
mitochondrial content in CRC and healthy intestinal tissues, as
shown by increased VDAC expression in Western blot analysis, are
similar with those obtained via immunocytochemical staining of
mitochondrial outer membrane translocase (Tom20) protein [58].
In conclusion, our oxygraphic experiments clearly showed that the
tissue neighboring to CRC contains a larger number of mitochon-
dria, exhibits high rates of OXPHOS (close to carcinoma cells) and
both these parameters exceed substantially the levels monitored
for healthy colon tissue cells.
3.2. Analysis of the coupling of hexokinase reactions with the OX-
PHOS system in CRC and surrounding tissues
Some tumor cells (e.g., breast cancer [44] along with HK-2
express type-1 hexokinase (HK-1) that like type-2 can bind to
VDAC and could mediate their highly glycolytic type [87]. In our
prior study, we have shown that human CRC cells are character-
ized by the presence of mitochondrially-bound HK-2 and that its
interaction with VDAC may be responsible for increased rates of
aerobic glycolysis in these cancer cells [58].
By using qRT-PCR, we estimated the levels of mRNA expression
for HK-1 and -2 in CRC, adjacent and healthy colon tissue. It was
found that HK-1 is expressed in each of the tissues examined in
comparable levels (Fig. 3), only for HK 2 the statistical difference
was signiﬁcant for tumor and control tissue (p¼0.01). Further, we
performed oxygraphic analysis of the coupling of HK with the
OXPHOS system in tumor, nearby and control tissues through the
stimulation of OXPHOS by mitochondrially-bound HK(s) due to
local generation of ADP. Experiments showed that the addition of
10 mM glucose to CRC and nearby tissue ﬁbers in the presence of
0.1 mMMg-ATP resulted in activation of mitochondrial respira-
tion, but this HK coupling with OXPHOS was absent in healthy
colon tissue (Fig. 4). In order to characterize the glucose effect on
mitochondrial respiration, we used the glucose index (IGLU); it
allows to compare the degree of stimulatory action of glucose
(through ADP released in HK reactions) with maximal ADP (2 mM)
activated respiration. As can be seen on Fig. 4B, the tissue neigh-
boring to CRC has similar value of IGLU (18.7%), for the malignancy
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Fig. 3. Q-PCR analysis of the levels of mRNA expression for hexokinase 1 and 2 in
human CRC and surroundings tissues; bars are SEM; p¼0.06 for HK 1 and p¼0.01
for HK 2. Average results for 29 CRC patients.IGLUE11.7%. HK activities are similar in CRC, nearby and healthy
colon tissues (Table 2), it could be assumed that mitochondria of
CRC and nearby tissue cells have a slightly higher capability for
hexokinase binding in comparison with normal intestinal tissue
cells and, as a consequence, slightly higher inclination to aerobic
glycolysis. The revealed bioenergetic difference showing that this
type of cancer cells could induce reprogramming of nearby tissue
cells towards aerobic glycolysis.
3.3. Western blot analysis of the levels of beta-tubulin isotypes in
healthy colon, CRC and the tumor surrounding tissue
To understand possible reasons for the observed large differ-
ence between CRC and normal intestinal tissues in their re-
spiratory parameters, we also examined the expression of main
beta-tubulin isoforms in these tissues. Prior studies have shown
that some β-tubulin isoforms may be involved in the regulation of
OXPHOS and cellular cytoarchitecture in muscle cells of oxidative
type. HK(s) can compete with tubulin for binding sites on the
VDAC. It was already shown that in HL-1 tumor cells the down-
regulation of β2-tubulin expression can mediate their Warburg
phenotype [45]. In this relation, we examined the spectrum of
main beta-tubulin isoforms expression in CRC and surrounding
non-tumorous tissues. Western blot analysis showed that there is
not any statistically-signiﬁcant difference in the levels of β-tubu-
lin-I, II and IV expression between CRC, healthy colon and nearby
tissues (Supplementary Fig 2). Only a slight ( 1.5-fold) increase
in the content of beta-III tubulin isotype was monitored in CRC in
comparison with nearby and control tissues (Fig. 5)
3.4. Interrelationship between expression of vascular endothelial
growth factors in CRC adjacent tissues and their respiratory activity
The ability of tumors to initiate the growth of new blood ves-
sels is one of the key molecular events during carcinogenesis. It
has been reported that the growth of solid tumors in vivo beyond
1–2 mm in diameter requires induction and maintenance of an
angiogenetic response [93]. This abnormal vascularization of tu-
mors may result in the development of microenvironments de-
prived of oxygen and nutrients [50]. As a consequence, hypoxic
cancer cells use glycolysis, instead of OXPHOS, as a primary me-
chanism of ATP production. Moreover, severe prolonged hypoxia
may affect OXPHOS or even cause irreversible damage of these
organelles in cancer cells. But, our data suggest that human col-
orectal carcinomas are not hypoxic, since display high rates of
OXPHOS (Fig. 1, and Table 2) due probably to extremely strong
stimulation of angiogenesis. To check this assumption, we in-
vestigated the expression of genes encoding the VEGF family and
its receptors (such as VEGF-A, -B, -C, FLT-1, FLT-4, KDR, NRP-1, and
NRP-2) in human CRC, neighboring and healthy colon tissues. The
role of VEGFs in promoting neovascularization and subsequent
growth of tumors is well established [67]. Our experiments
showed that the expression of gene encoding VEGF-A was pre-
dominant regardless of the examined tissue, since the levels of
mRNA for VEGF-B and -C were found to be nearly 2-times lower
(Fig. 6A). Among the VEGF receptors, the expression of FLT1 gene
was the predominant in tumor, whereas the level of FLT4 is low in
all tissue samples. Our studies suggest that a potent activation of
angiogenesis, both in CRC and neighboring tissues can occur. The
levels of VEGFs (A-C) expression in these tissues were found to be
excessive, when the results standardized with respect to the
control tissue for each patient separately (Fig. 6B). The ability of
CRC cells to produce VEGFs, that will result in development of new
blood and lymphatic vessels in the tumor growth area, is in good
agreement with previous in vitro and in vivo studies performed in
other laboratories [124,15,51,8,93]. In humans, angiogenesis is
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Fig. 9. Cutoff analysis of apparent Km (ADP) for control-tumor (A), and control-nearby (B) permeabilized samples. Vm values cutoff analysis was also performed for these two
datasets: (C) control-tumor and (D) control-nearby. For these calculations samples were taken from 46 patients.
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negligible levels of VEGFs can be observed. The relatively high
levels of VEGFs expression in healthy intestinal tissue (Fig. 6) could
be causally-linked with high regenerative activity of its
epithelium.
Besides, our data indicates that the process of neovasculariza-
tion provides sufﬁcient levels of nutrients and oxygen to support
high rates of OXPHOS in CRC and its surrounding non-tumorous
tissue cells (Table 2). So, among patients with CRC, a direct inter-
relationship between the level of VEGF-A expression and apparent
Km (ADP) values was monitored for nearby tissue samples
(Fig. 7B). A direct correlation between the level of VEGF-A ex-
pression and Vm values was found to occur in normal colon tissue
samples (Fig. 7A). However, such correlation was not observed for
CRC and nearby tissue samples. There was also no correlation
between other vascular endothelial growth factors expression and
these bioenergetics parameters.
3.5. Comparative analysis of regulation of mitochondrial respiration
in CRC, nearby and healthy intestinal tissue cells
3.5.1. Coupling of OXPHOS with creatine kinase and adenylate kinase
systems
Coupling of spatially separated intracellular ATP producing and
ATP-consuming systems is fundamental for the bioenergetics of
living organisms, ensuring a fail-safe operation of the energetic
system over a broad range of cellular functional activities. The
central cellular mechanism of functioning of these organized
metabolic pathways is the functional coupling between the iso-
enzymes of the creatine kinase (CK) and/or adenylate (AK) kin-
ase systems and mitochondrial adenine nucleotide translocase[100,31,32,45,46,55]. Human colonocytes express all CK iso-
enzymes, can form PCr, and it was found that BB-CK which is
characteristic for the brain, is also the predominant isoenzyme in
normal colon tissue [55,58,59]. The revealed downregulation of
uMtCK mRNA as well as oxygraphic analysis the coupling of MtCK
with OXPHOS in CRC tissue let us to conclude that mitochondria of
these carcinoma cells have a poor ability to synthesize PCr [58].
Our experiments showed that the nearby tissue is also character-
ized by downregulation of the CK system: a more than 2-fold fall
in the total CK activity was monitored (Table 1). Our in situ ex-
periments indicated that mitochondria in nearby tissue cells have
a decreased ability for the production of PCr like it was observed
for cancer tissue [58].
It is well-known that AK-catalyzed phosphotransfer plays one
of the key roles in the maintenance of energy homeostasis in fully
differentiated cells with a high-energy demand, such as neural,
cardiac and some skeletal muscle cells [31]. To assess the role of
AK in CRC cells, the presence of functional coupling between ANT
and OXPHOS was investigated. Recently we revealed that in hu-
man CRC cells the AK system is up-regulated in comparison with
healthy colon tissue, but the function of the system in nearby
tissue cells remained to be explored [58].
Experiments showed that the total AK activity of healthy in-
testine and nearby tissue extracts had similar values and they
were 40% lower as compared with CRC tissue (Table 1). These
results indicate that the AK system, in contrast to CK system, is up-
regulated in human colorectal carcinomas. Further, we compared
the degree of functional coupling of AK-catalyzed processes with
the OXPHOS system in CRC, nearby and non-tumor tissue samples.
Fig. 8A depicts typical tracings of a change in the rates of O2
consumption, which were obtained during these studies. The
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bilized CRC ﬁbers results in a remarkable (by 40%) increase in
the rate of O2 consumption by the samples (Fig. 8A). Addition of
exogenous cytochrome c had no effect on ADP-dependent re-
spiration indicting the intactness of MOM. Diadenosine penta-
phosphate (AP5A, an inhibitor of AK) at a concentration of 0.2 mM
suppressed the AMP-stimulated respiration up to initial level in-
dicating thereby that it was largely mediated by ADP produced in
AK reactions. Similar stimulatory effects of exogenously-added
AMP on mitochondrial respiration were monitored for all non-
tumorous tissues and they were notably (by about 1.5 times) lower
as compared with CRC samples. For more precise estimating of the
functional activity of AK processes and their coupling with the
OXPHOS system both in cancerous and normal surrounding tis-
sues, we applied the AK index (IAK) proposed by Gruno et al. [43].
The IAK measured for both non-neoplastic tissues (unaffected in-
testine: IAK¼0.3170.03; nearby tissue: IAK¼0.3970.04, n¼10)
were smaller as compared with CRC (IAK¼0.5070.02, n¼12)
(Fig. 8B). The reason of this difference may be the upregulation of
AK system and a stronger interaction between the AK and OXPHOS
system in comparison with nontumorous tissue. We assume that
this could partly mediate by higher activity of AK2 in carcinoma
cells in comparison with non-transformed cells. This will be
checked in our further studies.
3.5.2. Cutoff analysis of rates of maximal respiration, apparent Mi-
chaelis–Menten constant values for exogenously added ADP
For a better understanding of the functioning and regulation of
OXPHOS in human CRC cells and surrounding tissues, we mea-
sured their rates of maximal respiration as well as apparent Km
values for exogenously-added ADP. The obtained results were also
subjected to a cutoff analysis (based on random choice) for studies
of distribution of these respiratory parameters in tumor, control
and nearby tissues.
The analysis showed that there are strong differences in the
regulation of mitochondrial respiration between CRC, nearby and
unaffected tissue and it revealed the almost obvious signs the in-
ﬂuence of tumor on mitochondrial function in neighboring tissue.
Among the patients with CRC, the characteristic values of apparent
Km for ADP for tumor tissue cells were found to be considerably
smaller as compared with healthy large intestine (cutoff
value4134 mM) (Fig. 9A). Similarly, decreased Km (ADP) values
(very close to CRC cells) were also registered for nearby non-tu-
morous tissue cells; upon comparison of the data obtained for
healthy and the tumor neighboring tissue the corresponding cutoff
value was calculated as 4121 mM (Fig. 9B). The analysis of this
dataset led to the conclusion that Km normal values are above
120–130 mM, but pathological values will remain below this value.
The maximal rates of ADP activated respiration Vm measured for
permeabilized CRC and nearby tissue ﬁbers were found to exceed
signiﬁcantly that for healthy intestinal cells (Table 2) due most
probably to an increased amount of mitochondria in these tissue
cells. Appropriate test cutoff values were calculated (Fig. 9C and D)
and these could be used for diagnostics of CRC based on the
measurements of corresponding respiratory rates in biopsy ma-
terial. For control-tumor dataset the Vm cutoff value was calculated
as 0.88 nmol O2/min per mg dry weight of tissue (Fig. 9C) This
value is similar to the cutoff value found for the control-nearby
dataset (0.48 nmol O2/min per mg dry weight of tissue) (Fig. 9D).
Thus, the obtained data is showing that in situ the mitochon-
dria of human CRC and neighboring normal tissue have increased
afﬁnity towards adenine nucleotides as compared with healthy
colon tissue and these changes may appear in early stages of
carcinogenesis. Besides, the results raise the question about the
nature of tumor-associated factors which could inﬂuence the
bioenergetic function of mitochondria in neighboring normaltissue. These factors are not related to hypoxia, since the Vm values
characteristic for surrounding CRC tissue were even higher than
those for healthy colon tissue (Fig. 9).
3.5.3. Assessment of the homogeneity of mitochondrial populations
in CRC, nearby and control tissues
In addition, we evaluated heterogeneity of mitochondrial po-
pulations in CRC, nearby and normal tissue cells through analyzing
the kinetics of respiration of skinned ﬁbers with exogenously-ad-
ded ADP as proposed by [101]. Distinct mitochondrial sub-
populations could be present in these tissue cells and they could
differ in their OXPHOS capacity. In our studies, permeabilized ﬁ-
bers were treated with increasing concentrations of ADP, and the
measured rates of O2 consumption were plotted vs. ADP con-
centration in medium as double reciprocal Lineweaver–Burk plots,
according to a Michaelis–Menten equation. A linearization ap-
proach permits us to calculate corresponding Vm and Km values. As
has been shown by Saks and colleagues [101], the presence of two
kinetic phases of respiration regulation on a graph curve is an
indicator for the presence of two populations of mitochondria in a
cell, which have different afﬁnity for ADP and, correspondingly,
various Km and Vm parameters. Our studies showed that there are
not distinct mitochondrial subpopulations in CRC and neighboring
tissue cells (Fig. 10). But, in healthy bowel, very clearly two po-
pulations of mitochondria with very different properties are re-
vealed in double reciprocal plots. One population of mitochondria
is characterized with a low Km value (16.575.8 mM) but Km for the
second population is manifold higher (288767 mM) (Fig. 10). The
large difference in these apparent Km values for ADP (exceeding
the factor of nearly 20 times) explains why in this case two po-
pulations of mitochondria are possible to see. These two popula-
tions of mitochondria, most probably, represent different types of
ﬁbers in this normal colon sample: mucosa and smooth muscle.
Such a difference may be a reﬂection of the heterogeneity of
healthy colon tissue cellular composition; high Km values could be
attributed to mitochondria of the tissue cells with high OXPHOS
rates. Similar values of Km for ADP were monitored by us for rat
heart cardiomyocytes and soleus muscle cells. Low Km values for
exogenously-added ADP (in the range of 20–40 mM) are usually
characteristic for mitochondria of cells with high glycolytic rates,
such as gastrocnemius white (see Table 2) or some poorly differ-
entiated or tumor cells [47,60]. In the nearby tissue two popula-
tions of mitochondria are absent and the apparent Km value for
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Thus, we established that during colorectal carcinogenesis the
amount of mitochondria rises together with profound changes in
the regulation of the mitochondrial outer membrane permeability
for ADP.4. Discussion
Previous studies have shown that during malignant transfor-
mation the emerging cancer cells acquire new behavioral features
and profound changes in their energy metabolism, which in part
resemble undifferentiated embryonic cells, such as: invasive and
destructive growth, dissemination, higher glycolytic capacity even
in the presence of O2 [49,76,83]. The arising shifts in bioenergetics
of cancer cells provide them with high yields and rates of ATP
production, which are sufﬁcient to support high rates of biosyn-
thetic processes and proliferation even in hypoxic environment
[36]. Some signaling pathways underlying the Warburg phenotype
of malignant tumors are now uncovered and some therapeutic
strategies which target glycolysis in tumor cells have also been
proposed [115,74,89]. Currently, however, little is known about the
features of main energy producing systems and their functioning
in human CRC cells, although a deeper understanding of the spe-
ciﬁcity of bioenergetic processes which occur in the malignant
cells, is a prerequisite for the development of more effective
treatment strategies. To date, most of the corresponding studies
have been carried out on tumor cells grown in cultures, whose
proliferative, metabolic and bioenergetic properties may differ
cardinally from in vivo conditions. CRC is currently regarded as a
tumor of the Warburg phenotype [22,54,62], but our recent stu-
dies clearly showed that in situ human CRC cells have the total
glycolytic activity close to healthy tissue cells and that in these
malignant cells there is up-regulation of OXPHOS associated with
stimulation of mitochondrial biogenesis [58] (Tables 1 and 2).
These data were in good agreement with the results of other re-
searchers who showed that tumor cells are not intrinsically gly-
colytic and that not all tumors have mitochondria with OXPHOS
deﬁciency. The OXPHOS system was reported to be the principal
ATP producer (490%) for several malignant tumor cell types un-
der normoxic conditions [111,81]. Therefore, drug therapy target-
ing OXPHOS has emerged as an important alternative for growth
arrest of oxidative type tumors [81,83,96].
Recently, Witkiewicz and colleagues proposed a new con-
ceptual model for metabolism of a cancer cell at the tissue level
that sheds new light on the signiﬁcance of aerobic glycolysis,
linked with lactic acid production, in fueling tumor growth and
metastasis, and acting as a paracrine onco-metabolite [123]. This
phenomenon was called as the “reverse Warburg effect”, since
aerobic glycolysis occurred in stromal ﬁbroblasts, but not in epi-
thelial cancer cells [123]. In our work, in situ experiments were
carried out to reveal the presence of “parasitic” energy-transfer
interactions between CRC and neighboring tissue cells. For this
aim, we compared the glycolytic activity and the OXPHOS capacity
of CRC tissue cells with those in neighboring and distant healthy
intestinal tissue cells.
Taken together our in situ studies indicate that human CRC cells
in vivo exert a strong effect on the energy metabolism of neigh-
boring tissue cells, so that they acquire the bioenergetic para-
meters speciﬁc to the tumor itself. Nearby tissue samples are
characterized with upregulated mitochondrial respiration: values
of State 2 and State 3 respiration rates are close to the tumor cells
(Table 2). It is also found that nearby tissue is not purely glycolytic
(Table 1) and it contains active mitochondria with fully-functional
respiratory chain complexes (Fig. 1). Further work is needed to
clarify the nature of paracrine factors released by CRC cells, whichcould alter the energy metabolism in tumor neighboring tissue.
These can be various transforming growth factors (TGFs), as a large
proportion of colorectal cancers were found to be characterized by
elevated TGF-β production [13]. The growth of colorectal carci-
nomas is also associated with downregulation of the CK system in
nearby tissue cells (Table 2) as well as with profound alterations in
function of their mitochondria. In nearby tissue the mitochondria
exhibit increased afﬁnity to exogenously-added ADP similarly to
tumor mitochondria. The corresponding Km values were measured
as 93.677.7 mM for CRC cells and 84.979.9 mM for nearby tissue;
both these apparent Km (ADP) values were considerably (by almost
3 times) lower in comparison with distant healthy colon tissue
cells (256734 mM) (Table 1).
Our results indicate a very low probability that the nearby
tissue cell populations’ fuel via a lactate shunt the OXPHOS system
in CRC cells. We found that the postoperative samples derived
from CRC and neighboring tissue displayed practically equal values
of the glucose effect (Fig. 4), levels of HK-1 and HK-2 expression
(Fig. 3), and total glucose-phosphorylating activity (Table 1).
Our studies demonstrate that human CRC cannot be considered
as a pure hypoxic tumor, since the malignancy and its neighboring
tissue exhibit high rates of OXPHOS (Table 2). The respiration rates
for these tissues are even higher than in unaffected tissue. The
possible absence of acute hypoxic nature in colorectal carcinomas
is also conﬁrmed by their practically equal glucose-phosphor-
ylating capacity as compared with surrounding non-tumorous
tissues (Table 1), although hypoxia is a well-known factor that
strongly increases the dependence of cancer cells on glycolytic
pathway for ATP generation. Pioneering studies by Folkman de-
monstrated the crucial role of angiogenesis in tumor growth [34].
In the presented work, we found that there is some upregulation
of VEGFs (A, B, and C) and their receptors expression in CRC as well
as in the tumor surrounding tissue (Fig. 6). These might support
tumor growth by inducing neovascularization, providing thereby
O2 and substrates for cancer cell proliferation. It was already
proven that VEGF-B is abundantly expressed in tissues with
highly-active energy metabolism, where it could support sig-
niﬁcant metabolic functions [11]. It has generally been assumed
that in cancer cells, the upregulation of VEGFs is caused by a de-
ﬁciency in oxygen through HIF-1α pathways [27]. Co-expression of
HIF-1α with VEGFs has been already monitored in human CRC
tissue, and to be associated with poor prognosis [14]. But our
ﬁndings suggest that in human CRC cells HIF-1α is not the main
factor in the induction of VEGFs formation. The opinion [109,86]
that HIF-1α negatively regulates mitochondrial biogenesis and O2
consumption in tumor cells is doubtful, as in our previous work
we clearly showed (via TOM20 expression) that in human color-
ectal carcinomas mitochondrial biogenesis is upregulated [58].
Increased levels of VEGFs, as compared to healthy colon, were also
registered by us in nearby tissue (Fig. 6B). Recent ﬁndings suggest
that in some cases the tumor accessory cells, such as macrophages,
may be the main source of VEGFs promoting thereby neovascu-
larization and tumor proliferation [24]. In this relation, it was ro-
bustly demonstrated that some non-steroid anti-inﬂammatory
drugs (e.g., aspirin) lower risk of colorectal cancer-mediated
mortality [16]. Besides, it was reported [27] that cancer-associated
ﬁbroblasts can express increased levels of VEGFs, thereby con-
tributing to angiogenesis and tumor progression. Multiple clinical
trials using antiangiogenic agents blocking VEGFs have recently
demonstrated high efﬁcacy for patients with metastatic colorectal
cancer [23]. Our results show a correlation between the level of
VEGF-A expression and maximal mitochondrial respiration rate Vm
occurring in healthy colon tissue (Fig. 7A), but in tumor nearby
tissue this correlation is replaced by a relationship between VEGF-
A expression and the mitochondrial outer membrane permeability
for ADP (Fig. 7B). The reason for this is not clear yet.
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of OXPHOS as compared to normal tissue cells (Table 2) [58]. This
is surprising, since it has been reported [102,122] that β-F1-ATPase
catalytic subunit of the mitochondrial Hþ-ATP synthase is down-
regulated in human colorectal carcinomas, and this is associated
with the upregulation of the ATPase inhibitory factor 1 expression
[35]. These changes should be associated with severe suppression
of OXPHOS capacity, but our results do not conﬁrm this. Our re-
sults support the hypothesis proposed by Pedersen and coworkers
[89] that in tumor cells the presence of mitochondrially-bound
HK-2 can be responsible for their increased rates of aerobic gly-
colysis. We found that the addition of glucose to permeabilized
ﬁbers (in the presence of exogenous ATP) resulted in some sti-
mulation of mitochondrial respiration, not only in CRC, but also in
neighboring samples. This effect, on the contrary, was negligible
for healthy colon tissue cells (Fig. 4). The minor effect of glucose on
mitochondrial respiration of permeabilized ﬁbers derived from
unaffected tissue samples was initially confusing; all examined
tissues are characterized by the presence of mitochondrially-
bound HK-2 [58], but have different levels of HK-1 and HK-2 ex-
pression (Fig. 3). At the same time, it was reported that mi-
tochondria of tumor cells have elevated binding capacity towards
HK-1 and -2 as compared with normal cells due to an increased
number of VDAC(s) per mitochondria and cholesterol content in
the MOM [87]. Elevated levels of VDAC protein (a binding partner
for HKs) were registered by us in human CRC tissue cells, as
compared to healthy colon tissue (Fig. 2), and this may be a
plausible explanation for the negligible stimulating effect of exo-
genously added glucose on mitochondrial respiration in the nor-
mal tissue cells (Fig. 4) in spite of similar with cancerous tissue the
levels of HK 1 expression (Fig. 3). Although several isoforms of
VDAC are known, they do have similar kinetic characteristics,
which indicate that the contribution of VDAC to enhanced HK
binding and glucose phosphorylation is due to quantitative dif-
ferences in binding site availability [105]. The distribution and role
of HK isoforms in CRC and surrounding tissues in situ need further
studies.
CK plays a key role in the energy homeostasis of vertebrate
cells. It has been shown by us and other researchers that during
carcinogenesis there is a nearly 2 times decrease in the total CK
activity (Table 1) associated with loss of BB-CK (predominant
isoform of CK in normal intestinal tissue) MM-CK, sMtCK and
uMtCK [55,58]. Also, in our prior study [58] we showed that nor-
mal intestinal cells have elevated levels of uMtCK expression and
these cells are characterized by, on contrary to CRC cells, tight
coupling between the CK isoform and OXPHOS system like in
cardiac and slow-twitch skeletal muscle cells [114,47,78]. Down-
regulation of the CK system (associated with loss of uMtCK) was
registered by us and also others tumors with different histological
type, such as human breast carcinoma [56], neuroblastoma [60]
and sarcoma cells [88,9]. Possible signaling pathways mediating
the downregulation of CK system in HCC cells remain still unclear.
It was proposed that the downregulation of BB-CK in human CRC
cells may play an important role in the tumor progression [80]. In
the presented work, we found that colorectal carcinomas exert a
distant effect on neighboring cells resulting in downregulation of
their CK system (Table 1). The revealed absence of stimulating
effect of exogenous creatine on mitochondrial respiration in CRC
and nearby samples, contrary to healthy intestinal tissue, shows
that mitochondria in both these tissues lose their ability to pro-
duce PCr. Our ﬁndings, on the poor ability of human CRC cells
mitochondria to produce the marked amount of PCr, are in good
agreement with literature data [59]. Although during CRC pro-
gression the arising malignant cells were found to up-regulate
their AK system (Table 1) and there is tight coupling of the syst-
em with OXPHOS (Fig. 8, perhaps partly via upregulation ofmitochondrial AK2), the distant effect of the neoplasm on AK
processes in surrounding tissue cells was found to be minor (Ta-
ble 1 and Fig. 8). We assume that the revealed downregulation of
CK system may be casually-linked with upregulation of the AK
phosphotransfer system. Indeed, we found that in human CRC cells
the total AK activity exceeded signiﬁcantly from that of normal
intestinal tissue cells (Table 1) and it has also been reported by
Dzeja et al. [33] that suppression of CK-catalyzed phosphotransfer
may result in increased phosphoryl transfer by AK in intact ske-
letal muscle. But in contrast to our ﬁndings concerning CRC, the
total AK activity in human lung adenocarcinomas was found to be
substantially less as compared with normal tissue [41].
In oxidative type tissues with high energy demand the OXPHOS
system is organized into protein supercomplexes, called the Mi-
tochondrial Interactosome (MI) [113,45,79,99]. MI is a large trans-
membrane complex consisting of ATP-Synthasome, MtCK, VDAC,
and protein factors regulating the outer mitochondrial membrane.
There also some indication that the mitochondrial supercomplex
may include certain HK(s) [74] as well as AK2 and AK4 [69]. From
our studies it becomes clear that during carcinogenesis the
structure and function of MI in colonocytes undergoes severe and
speciﬁc alterations. Moreover, our results strongly suggest that
colorectal carcinomas exert, by a currently unknownway, a distant
effect on the functioning of MI in neighboring tissue cells. These
alterations provide the basis for successful proliferation and via-
bility of malignant cells in the hostile environment, characterized
by deﬁciency in oxygen and nutrients. It is important to emphasize
that in tumor cells, in addition to the MI, substantial alterations
were also found to occur in the organization of mitochondrial
respiratory chain: some enzymes of the ETC can form large su-
percomplexes that in turn may promote the generation of ATP
[2,56,57,60]. Indeed, our studies showed that the MOM in CRC and
nearby tissue cells has increased permeability towards adenine
nucleotides and they display an increased afﬁnity for exogenous
ADP. Thus, the apparent Km values for exogenously-added ADP
measured for CRC and the neighboring tissue cells were found to
be considerably (by about 3 times) smaller in comparison with
that for distant normal tissues samples (Table 2). Our results and
an analysis of literature data allowed us to propose several pos-
sible explanations for this phenomenon. Firstly, our results in-
dicate that CRC and neighboring tissue cells, as compared to
control colon tissue, contain higher levels of VDAC (Fig. 2) and,
consequently, they can bind much more HK-2 [87]. The presence
of mitochondrially-bound HK-2 in CRC and control intestinal tis-
sues was adjusted by our immunoﬂuorescent studies [58]. This
event can mediate lower Km for ADP, since the binding of HK to
VDAC holds this channel in the opened state [98] or then some
other unknown protein factors could be involved in this phe-
nomenon. Secondly, the revealed downregulation of MtCK and the
absence of creatine kinase energy transfer network in CRC and
neighboring tissue cells could be also responsible for increased
permeability of the MOM [114,45]. Thirdly, it is known that some
ß-tubulin isoforms can bind to the VDAC localized on MOM and
suppress its permeability towards adenine nucleotides, mediating
thereby higher Km values for ADP and high rates of PCr production
[114,47]. Western blot analysis showed similar levels of ß-tubulin
isoforms (I, II, III and IV) expression in CRC, healthy colon and
nearby tissue samples (Fig. 5) and no binding of ßII-tubulin to
VDAC(s) was also registered in these tissues [58]. This result is not
in accordance with the data obtained on pure oxidative cells (rat
heart cardiomyocytes) [112,46] and the question arises, what
complex is interacting with VDAC and therefore possibly regulat-
ing its permeability. This question remains the key in under-
standing the regulation mechanism of ATP production in mi-
tochondria, not only in cardiac and muscle cells, but also in cells of
the CRC. Tubulin and its potential biding partner – VDAC can
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[53,87], which may deeply affect their interactions. Fourthly, hu-
mans encode three different VDACs; VDAC1, VDAC2, and VDAC3,
which were found to display different binding capacity towards
tubulin, and the VDAC3 permeability is not sensitive to tubulin
regulation [72]. In this relation, we propose that in CRC and
neighboring non-tumor tissue cells, having lowered apparent Km
values for ADP (Table 2) the VDAC3 isoform may be predominant.
In addition, remarkable differences in the proﬁle of ANT isoforms
expression between normal and cancerous tissue cells could be
responsible for the increased permeability of MOM in tumor cells.
Cancer cells express predominantly ANT2, which interacts with
VDAC [20,21], and this could result in a facilitated diffusion ade-
nine nucleotides across the MOM.
The increased level of β-III tubulin expression in colorectal
carcinomas (Fig. 5) was also registered in other laboratories, and
this may contribute to cancer cell invasion [66,84].5. Conclusion
This study revealed several important aspects in the bioener-
getic metabolism of CRC and surrounding tissues cells. For a long
time aerobic glycolysis has been considered the main energy
source in CRC cells, but our results strongly suggest that CRC
should not be considered a hypoxic tumor, since the malignancy
exhibits high (even more than healthy colon tissue) rates of oxy-
gen consumption, increased amount of mitochondria and practi-
cally equal glucose-phosphorylating capacity with the surround-
ing tissues. Obvious signs of stimulated neovascularization in CRC
and nearby tissue are also evident. We observed strong differences
in the function and regulation OXPHOS between CRC and normal
intestinal tissue cells. During carcinogenesis, the amount of mi-
tochondria is increasing in parallel to the change in the regulation
of mitochondrial outer membrane permeability and phospho-
creatine/creatine kinase shuttle that is completely replaced with
AK mediated energy transport. The malignant cells are character-
ized by downregulation of CK, which is further associated with
upregulation of the AK system and this could promote tumor
growth and metastasis. The mitochondria of CRC cells lose the
ability to produce PCr, reveal possibility of coupling of HK to OX-
PHOS and have increased afﬁnity for ADP. In this aspect, more
studies are required to determine the proﬁle of AK, ANT and VDAC
isoforms expression in human colorectal carcinomas. One of the
most important ﬁndings from our studies is also that CRC cells
exert a potent distant effect on the energy metabolism of nearby
tissue cells. As compared with healthy colon tissue cells, nearby
cells are also characterized by stimulated OXPHOS, down-
regulation of the CK system, which is associated with the loss of
MtCK and increased permeability of the MOM against adenine
nucleotides. Our data refused the initial hypothesis according to
which the CRC surrounding cells could fuel via a lactate shunt the
OXPHOS system in the malignancy cells.Acknowledgments
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